
Reports find $128 billion in hospital-based drug spending, and Part B disincentives

Better local resources around the world and more sophisticated technology are changing the dynamics of logistics services

A new, market-driven model of drug development and commercialization is appearing*

Looking at 'cost' and 'value' under different evaluation processes

Quad-C investment will enable future acquisitions

MarkMonitor updates its surveillance surveys against counterfeiting and drug diversion

Canada's Rexall chain, plus Biologics, Inc, and Vantage Oncology

New healthcare proposals re-open talk of drug importation

Government at all levels are trying to mobilize to address the crisis

Friction continues with Express Scripts as well

Global drug-wholesaler group plans future educational and developmental work

New subsidiary will look at common industry problems in preclinical work

New survey finds more digitally-savvy healthcare providers, challenging reps' presentation capabilities

Marken offers tailored logistics services to research community

Latest 'delegated regulation' of the Falsified Medicines Directive is promulgated

Acsis polls industry sentiment; TraceLink touts doubling of revenue

IT vendor offers a service to measure TMF capabilities

TGaS Advisors expands its roster of services

Outsourced services can provide significant financial and risk-avoidance benefits

Good growth is occurring in the vaccine business, despite the hurdles of public perceptions and public-health funding shortfalls


The rise in product volume is more than matched by the rise of regulatory constraints

A 'performance curve' chart for containers could simplify the design process


Design analysis can dictate blister composition


Looking at the essential value of well-managed supply chains

IMS Health/Ego Zender survey of CIOs finds short tenures and evolving skill sets

Office of Prescription Drug Promotion finds little to complain about